Amgen reportedly in talks to buy Horizon Therapeutics

Amgen reportedly in talks to buy Horizon Therapeutics

Amgen Inc. is in advanced talks to buy drug company Horizon Therapeutics PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. The U.S. biotechnology company AMGN, -2.42% was the last of three suitors standing in an auction for Horizon HZNP, +0.39%, the…

Here’s how some Dow industrials companies are observing the Juneteenth holiday

Here’s how some Dow industrials companies are observing the Juneteenth holiday

The Dow Jones Industrial Average won’t be trading on Monday when the new Juneteenth federal holiday is observed, because the stock market will be closed, and so will many of the Dow’s components. That’s a relatively quick turnaround for the New York Stock Exchange and Nasdaq exchange to close for Juneteenth, just one year after…

Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting

Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting

The stocks for companies developing cancer therapies were moving in morning trading on Friday as biotechs and researchers shared new clinical findings in advance of next week’s American Society of Clinical Oncology annual meeting.  Here’s a recap of Friday’s big premarket moves: Arcellx Inc.’s ACLX, +20.56% stock jumped 11.9% after an abstract provided updated data…